These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17337502

  • 1. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.
    Thorn LM, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Kilpikari R, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2007 May; 30(5):1162-7. PubMed ID: 17337502
    [Abstract] [Full Text] [Related]

  • 2. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.
    Wadén J, Forsblom C, Thorn LM, Saraheimo M, Rosengård-Bärlund M, Heikkilä O, Hietala K, Ong K, Wareham N, Groop PH, FinnDiane Study Group.
    Diabetes; 2009 Aug; 58(8):1914-20. PubMed ID: 19491208
    [Abstract] [Full Text] [Related]

  • 3. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.
    Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Grönhagen-Riska C, Parving HH, Groop PH.
    Diabetes; 1998 Mar; 47(3):439-44. PubMed ID: 9519751
    [Abstract] [Full Text] [Related]

  • 4. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH.
    Diabetes Care; 2000 Jan; 23(1):30-3. PubMed ID: 10857964
    [Abstract] [Full Text] [Related]

  • 6. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy.
    Earle K, Walker J, Hill C, Viberti G.
    N Engl J Med; 1992 Mar 05; 326(10):673-7. PubMed ID: 1736105
    [Abstract] [Full Text] [Related]

  • 7. The impact of parental risk factors on the risk of stroke in type 1 diabetes.
    Ylinen A, Hägg-Holmberg S, Eriksson MI, Forsblom C, Harjutsalo V, Putaala J, Groop PH, Thorn LM, FinnDiane Study Group.
    Acta Diabetol; 2021 Jul 05; 58(7):911-917. PubMed ID: 33721078
    [Abstract] [Full Text] [Related]

  • 8. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
    Roglic G, Colhoun HM, Stevens LK, Lemkes HH, Manes C, Fuller JH.
    Diabet Med; 1998 May 05; 15(5):418-26. PubMed ID: 9609365
    [Abstract] [Full Text] [Related]

  • 9. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH, Finnish Diabetic Nephropathy Study Group.
    Diabetes; 2009 Nov 05; 58(11):2649-55. PubMed ID: 19651819
    [Abstract] [Full Text] [Related]

  • 10. Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients.
    Rudberg S, Stattin EL, Dahlquist G.
    Diabetes; 1998 Jul 05; 47(7):1121-6. PubMed ID: 9648837
    [Abstract] [Full Text] [Related]

  • 11. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
    Möllsten A, Jorsal A, Lajer M, Vionnet N, Tarnow L.
    Diabetologia; 2009 Dec 05; 52(12):2590-3. PubMed ID: 19834686
    [Abstract] [Full Text] [Related]

  • 12. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women.
    Gordin D, Hiilesmaa V, Fagerudd J, Rönnback M, Forsblom C, Kaaja R, Teramo K, Groop PH, FinnDiane Study Group.
    Diabetologia; 2007 Mar 05; 50(3):516-22. PubMed ID: 17216281
    [Abstract] [Full Text] [Related]

  • 13. Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients.
    Hadjadj S, Duengler F, Torremocha F, Faure-Gerard G, Bridoux F, Boissonnot M, Mauco G, Guilhot J, Maréchaud R.
    Diabetes Metab; 2007 Feb 05; 33(1):37-43. PubMed ID: 17258929
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.
    De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC.
    Diabetologia; 1997 Oct 05; 40(10):1191-6. PubMed ID: 9349601
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.
    Diabetes Care; 2008 Apr 05; 31(4):747-52. PubMed ID: 18162497
    [Abstract] [Full Text] [Related]

  • 16. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.
    Gordin D, Harjutsalo V, Tinsley L, Fickweiler W, Sun JK, Forsblom C, Amenta PS, Pober D, D'Eon S, Khatri M, Stillman IE, Groop PH, Keenan HA, King GL.
    Diabetes Care; 2018 Apr 05; 41(4):815-822. PubMed ID: 29386250
    [Abstract] [Full Text] [Related]

  • 17. Low birth weight does not increase the risk of nephropathy in Finnish type 1 diabetic patients.
    Fagerudd J, Forsblom C, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Thorn L, Wessman M, Groop PH, FinnDiane Study Group.
    Nephrol Dial Transplant; 2006 Aug 05; 21(8):2159-65. PubMed ID: 16702205
    [Abstract] [Full Text] [Related]

  • 18. The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus.
    Fagerudd JA, Pettersson-Fernholm KJ, Grönhagen-Riska C, Groop PH.
    Diabetologia; 1999 May 05; 42(5):519-26. PubMed ID: 10333042
    [Abstract] [Full Text] [Related]

  • 19. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec 05; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

  • 20. Genetic susceptibility and the role of hypertension in diabetic nephropathy.
    Fogarty DG, Krolewski AS.
    Curr Opin Nephrol Hypertens; 1997 Mar 05; 6(2):184-91. PubMed ID: 9146982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.